Last update: Oct. 15, 2014
Poorly safe. Evaluate carefully.
Use safer alternative or interrupt breastfeeding 3 to 7 T ½ (elimination half-lives).
Read the Comment.
African type anti-trypanosomal drug (T.Gambiense, Sleeping disease). Treatment is recommended for 7 days long. There is not any experience with this drug on breastfeeding to make a recommendation. Assess risk-benefit ratio and mother’s condition closely, which is usually precarious. In any case, check-up for side effects on both the mother and the baby. Because of such short-term treatment, a temporally breastfeeding withholding may be scheduled. Melarsoprol is a much less toxic drug, unfortunately, the industry do not regard it as being profitable enough to assure a continuing access of poor patients to the latter drug.
Suggestions made at e-lactancia are done by APILAM´s pediatricians and pharmacists, and are based on updated scientific publications.
It is not intended to replace the relationship you have with your doctor but to compound it.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
e-lactancia is a resource recommended by Instituto de Salud Infantil, Grecia-Institute of Child's Health in Greece
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM